The Brazil hemostats market was valued at USD 230.13 Million in 2025 driven by the rising surgical volumes across the region. It is expected to grow at a CAGR of 5.80% during the forecast period of 2026-2035 and attain a market value of USD 404.42 Million by 2035. Brazil relies on both domestic production and foreign suppliers for medical devices.
Multinational companies have targeted Brazil as a priority market in Latin America, expanding distribution networks and offering localized training for surgical staff to support product adoption. There's growing interest in absorbable hemostats, especially those based on collagen and oxidized cellulose, as these products are easier to use and often reduce operating time. Additionally, the country's robust public health system, led by the Brazilian Unified Health System (SUS), supports wide access to surgical care, boosting demand for hemostatic agents.
Base Year
Historical Period
Forecast Period
Rising cardiovascular disease burden is fueling demand for effective bleeding control solutions in Brazilian surgical procedures.
The market growth is driven by expanding healthcare investments in Brazil, that support greater adoption of advanced hemostatic agents in public and private hospitals.
One of the major market trends include increasing use of minimally invasive surgeries is driving demand for absorbable and endoscopic hemostats across Brazilian healthcare facilities.
Compound Annual Growth Rate
5.8%
Value in USD Million
2026-2035
*this image is indicative*
Hemostats are widely used in Brazil to control bleeding during surgeries and traumatic injuries, ensuring a clear surgical field and reducing complications. Their use is rising due to increased surgical procedures, a growing elderly population, and a high prevalence of chronic diseases like diabetes and cardiovascular conditions, which require frequent surgical intervention and effective bleeding management. The Brazil hemostats market is expected to grow at a CAGR of 5.80% during the forecast period of 2026-2035 across the region.
Technological Innovation and Surgical Demand Driving Brazil Hemostats Market
The rising prevalence of cardiovascular diseases and the growing number of surgical interventions in Brazil are driving the demand for effective bleeding control solutions. The market is further supported by advancements in hemostatic technologies, enhancing surgical outcomes. Continuous innovation in product development is improving patient safety and treatment efficacy, thereby encouraging the adoption of healthcare facilities. These factors collectively position the market for robust growth throughout the forecast period, meeting increasing clinical needs and improving procedural success rates.
Major market trends include growing surgical volumes and healthcare investments.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Formulation
Market Breakup by Application
Market Breakup by Indication
Market Breakup by End User
Cardiovascular and Cardiothoracic to Lead the Segmentation by Application
The cardiovascular and cardiothoracic segment is poised to hold the largest market share due to the high prevalence of cardiovascular diseases requiring surgical interventions. Rising cases of heart disease and related complications drive demand for effective bleeding control during complex surgeries. Additionally, technological advancements in cardiovascular procedures and increased healthcare infrastructure investments support market growth. This segment’s critical need for reliable hemostatic agents positions it as the dominant application area during the forecast period.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson Services Inc., headquartered in New Brunswick, New Jersey, was established in 1886. It offers a broad portfolio of medical devices, pharmaceuticals, and consumer health products. In the hemostats market, Johnson & Johnson provides advanced surgical hemostatic agents and wound care solutions, driving innovation and improving patient outcomes globally.
Baxter International, founded in 1931 and based in Deerfield, Illinois, specializes in medical devices, pharmaceuticals, and biotechnology. Its portfolio includes hemostatic products, infusion therapies, and surgical care solutions, focusing on improving treatment efficacy and patient safety in hospitals and clinics worldwide.
Pfizer Inc., established in 1849 and headquartered in New York City, is a global pharmaceutical leader. It offers a wide range of medicines and vaccines, including innovative therapies for bleeding control and surgical applications, contributing significantly to advancements in the hemostats and surgical care market.
B. Braun SE, founded in 1839 and based in Melsungen, Germany, is a leading medical device and pharmaceutical company. It provides hemostatic agents, surgical instruments, and infusion therapies, focusing on enhancing surgical outcomes and patient safety across global healthcare settings.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Becton, Dickinson and Company (BD), Medtronic plc, and Stryker Corporation.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Formulation |
|
| Breakup by Application |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share